Innovate to care

Your partner in lateral flow test development
View case study
Latest News

Our expertise

Latest news

By GADx Team

Reflections from the International Pandemic Sciences Conference 2024 

The historic city of Oxford recently played host to the International Pandemic Sciences Conference 2024, an event that drew over 450 delegates from around the world. Held at the…
By Dr James Schouten

GADx Contributes to TB Diagnostic Advancements 

GADx is pleased to announce its significant contribution to a groundbreaking study published in PLoS One. The research, titled "Performance of Novel Antibodies for Lipoarabinomannan to Develop Diagnostic Tests…
By Dr Andrew Wheeler

Global Access Diagnostics (GADx) selected as member of ARPA-H Investor Catalyst Hub spoke network

Global Access Diagnostics (GADx) has been selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health innovation network launched by the Advanced…
More news

Frequent testing is invaluable and so it is vital to find ways to drive down the cost of kits and increase production levels. As a social enterprise, GADx can transform this process because it ‘breaks the link’ of ‘having to make profit for shareholders’.

Paul Davis
Co-founder of Mologic and pioneer of lateral flow diagnostics.